Lowenstein Sandler represented Maxim Group LLC as sole book-running manager for the $13.1 million underwritten public offering for Provectus Biopharmaceuticals Inc. The Lowenstein deal team included Steven M. Skolnick, Robert J. Paradiso, James B. O'Grady, Irina Ishak and Brandon Greenblatt.